View in EDS HTML Full Text PDF Full Text

Intranasal Multiepitope PD‐L1‐siRNA‐Based Nanovaccine: The Next‐Gen COVID‐19 Immunotherapy.

Saved in:
Bibliographic Details
Title: Intranasal Multiepitope PD‐L1‐siRNA‐Based Nanovaccine: The Next‐Gen COVID‐19 Immunotherapy.
Authors: Acúrcio, Rita C.1 (AUTHOR), Kleiner, Ron2 (AUTHOR), Vaskovich‐Koubi, Daniella2 (AUTHOR), Carreira, Bárbara1 (AUTHOR), Liubomirski, Yulia2 (AUTHOR), Palma, Carolina1 (AUTHOR), Yeheskel, Adva3 (AUTHOR), Yeini, Eilam2 (AUTHOR), Viana, Ana S.4 (AUTHOR), Ferreira, Vera1 (AUTHOR), Araújo, Carlos1 (AUTHOR), Mor, Michael5 (AUTHOR), Freund, Natalia T.5 (AUTHOR), Bacharach, Eran6 (AUTHOR), Gonçalves, João1 (AUTHOR), Toister‐Achituv, Mira7 (AUTHOR), Fabregue, Manon8 (AUTHOR), Matthieu, Solene8 (AUTHOR), Guerry, Capucine8 (AUTHOR), Zarubica, Ana8 (AUTHOR)
Source: Advanced Science. 10/28/2024, Vol. 11 Issue 40, p1-18. 18p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21983844
DOI:10.1002/advs.202404159